Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 8/20 | 0.59 |
| ▸ | CTSB | P07858 | 8/20 | 0.59 |
| ▸ | CTSS | P25774 | 12/20 | 0.55 |
| ▸ | CTSK | P43235 | 3/20 | 0.52 |
| ▸ | CTSH | P09668 | 1/20 | 0.52 |
| ▸ | CTSC | P53634 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8691327 | 0.96 | CTSB (0.55) | CTSLCTSBCTSSCTSKCTSH | |
| SCHEMBL8159870 | 0.82 | CTSL (0.66) | CTSLCTSBCTSSCTSKCTSH | |
| SCHEMBL7414213 | 0.81 | CTSL (0.70) | CTSLCTSBCTSSCTSKCTSH | |
| SCHEMBL7414216 | 0.81 | CTSL (0.70) | CTSLCTSBCTSSCTSKCTSH | |
| SCHEMBL8696030 | 0.81 | CTSL (0.70) | CTSLCTSBCTSSCTSKCTSH | |
| SCHEMBL8696034 | 0.81 | CTSL (0.70) | CTSLCTSBCTSSCTSKCTSH | |
| SCHEMBL8156094 | 0.79 | CTSL (0.55) | CTSLCTSBCTSSCTSKCTSH | |
| SCHEMBL7411947 | 0.79 | CTSS (0.58) | CTSLCTSBCTSSCTSKCTSH | |
| SCHEMBL8691957 | 0.78 | CTSS (0.55) | CTSLCTSBCTSSCTSKCTSH | |
| SCHEMBL8369487 | 0.78 | CTSL (0.56) | CTSLCTSBCTSSCTSKCTSH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5776718-A | Reversible protease inhibitors | ARRIS PHARMACEUTICAL CORPORATION (US) | 1998-07-07 | — | — | US | disclosed |
| EP-0817778-A1 | REVERSIBLE PROTEASE INHIBITORS | ARRIS PHARMACEUTICAL CORPORATION (US) | 1998-01-14 | — | — | EP | disclosed |
| WO-1996030353-A1 | REVERSIBLE PROTEASE INHIBITORS | ARRIS PHARMACEUTICAL CORPORATION (US) | 1996-10-03 | — | — | WO | disclosed |